Goldenwell Biotech, Inc. GWLL
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -85.49% | -21.64% | -45.75% | 850.00% | 197.67% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -100.00% | 0.06% | 0.06% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -88.46% | -90.20% | -83.90% | 22.85% | 25.40% |
|
|
|||||
| Total Current Assets | -88.46% | -90.20% | -83.90% | 22.85% | 25.40% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -88.46% | -90.20% | -83.90% | 22.85% | 25.40% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 55.28% | 5,163.16% | 5,263.16% | 3,183.33% | 5,266.67% |
| Total Other Current Liabilities | 55.28% | 5,163.16% | 5,263.16% | 3,183.33% | 5,266.67% |
| Total Current Liabilities | 55.28% | 1,566.67% | 5,263.16% | 3,183.33% | 5,266.67% |
|
|
|||||
| Total Current Liabilities | 55.28% | 1,566.67% | 5,263.16% | 3,183.33% | 5,266.67% |
| Long-Term Debt | 19.50% | 3.09% | 3.12% | 39.70% | 40.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.35% | 36.87% | 39.94% | 58.63% | 71.97% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retained Earnings | -22.26% | -19.70% | -21.81% | -5.68% | -6.92% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -358.76% | -321.10% | -628.18% | -393.75% | -2,384.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -358.76% | -321.10% | -628.18% | -393.75% | -2,384.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -358.76% | -321.10% | -628.18% | -393.75% | -2,384.21% |
|
|
|||||